These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23735316)

  • 21. Nanoscale delivery systems for multiple drug combinations in cancer.
    Cao Y; Wang B; Lou D; Wang Y; Hao S; Zhang L
    Future Oncol; 2011 Nov; 7(11):1347-57. PubMed ID: 22044207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transport barriers and strategies of antitumor nanocarriers delivery system.
    Zhang L; Wang Y; Cao Y; Lou D; Wang B
    J Biomed Mater Res A; 2013 Dec; 101(12):3661-9. PubMed ID: 23983207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles.
    Sinek J; Frieboes H; Zheng X; Cristini V
    Biomed Microdevices; 2004 Dec; 6(4):297-309. PubMed ID: 15548877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cellular adaptations to hypoxia as novel therapeutic targets in childhood cancer.
    Adamski JK; Estlin EJ; Makin GW
    Cancer Treat Rev; 2008 May; 34(3):231-46. PubMed ID: 18207646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems.
    Kratz F; Warnecke A
    J Control Release; 2012 Dec; 164(2):221-35. PubMed ID: 22705248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of Drug Resistance Related to the Microenvironment of Solid Tumors and Possible Strategies to Inhibit Them.
    Tan Q; Saggar JK; Yu M; Wang M; Tannock IF
    Cancer J; 2015; 21(4):254-62. PubMed ID: 26222076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Numerical simulation of the tumor interstitial fluid transport: Consideration of drug delivery mechanism.
    Moghadam MC; Deyranlou A; Sharifi A; Niazmand H
    Microvasc Res; 2015 Sep; 101():62-71. PubMed ID: 26122936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug development for cancer chemoprevention: focus on molecular targets.
    Johnson KA; Brown PH
    Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
    Danhier F; Feron O; Préat V
    J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifactorial nature of tumor drug resistance.
    Solyanik GI
    Exp Oncol; 2010 Sep; 32(3):181-5. PubMed ID: 21403614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug.
    Hamad I; Moghimi SM
    Expert Opin Drug Deliv; 2008 Feb; 5(2):205-19. PubMed ID: 18248319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
    Chen JN; Shen Q; Li SS
    Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metronomic chemotherapy: Back to the future!
    André N; Padovani L; Verschuur A
    Drug News Perspect; 2010 Mar; 23(2):143-51. PubMed ID: 20369080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics.
    Steichen SD; Caldorera-Moore M; Peppas NA
    Eur J Pharm Sci; 2013 Feb; 48(3):416-27. PubMed ID: 23262059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mathematical modeling analysis of intratumoral disposition of anticancer agents and drug delivery systems.
    Popilski H; Stepensky D
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):767-84. PubMed ID: 25813659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug targeting and tumor heterogeneity.
    Bae YH
    J Control Release; 2009 Jan; 133(1):2-3. PubMed ID: 18848589
    [No Abstract]   [Full Text] [Related]  

  • 38. Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery.
    Stapleton S; Jaffray D; Milosevic M
    Adv Drug Deliv Rev; 2017 Jan; 109():119-130. PubMed ID: 27262923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticles for delivery of chemotherapeutic agents to tumors.
    Vijayaraghavalu S; Raghavan D; Labhasetwar V
    Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the VEGF/VEGFR axis in cancer biology and therapy.
    Rapisarda A; Melillo G
    Adv Cancer Res; 2012; 114():237-67. PubMed ID: 22588059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.